BlackRock Investment Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $1.15M | Buy |
68,213
+190
| +0.3% | +$3.21K | ﹤0.01% | 2607 |
|
2016
Q3 | $1.12M | Sell |
68,023
-118
| -0.2% | -$1.94K | ﹤0.01% | 2580 |
|
2016
Q2 | $1.03M | Buy |
68,141
+18,365
| +37% | +$278K | ﹤0.01% | 2605 |
|
2016
Q1 | $720K | Buy |
49,776
+9,068
| +22% | +$131K | ﹤0.01% | 2703 |
|
2015
Q4 | $1.15M | Buy |
40,708
+204
| +0.5% | +$5.78K | ﹤0.01% | 2487 |
|
2015
Q3 | $678K | Buy |
40,504
+1,346
| +3% | +$22.5K | ﹤0.01% | 2879 |
|
2015
Q2 | $1.03M | Buy |
39,158
+30,588
| +357% | +$802K | ﹤0.01% | 2737 |
|
2015
Q1 | $150K | Buy |
8,570
+58
| +0.7% | +$1.02K | ﹤0.01% | 3243 |
|
2014
Q4 | $148K | Hold |
8,512
| – | – | ﹤0.01% | 3281 |
|
2014
Q3 | $158K | Buy |
8,512
+731
| +9% | +$13.6K | ﹤0.01% | 3251 |
|
2014
Q2 | $142K | Buy |
+7,781
| New | +$142K | ﹤0.01% | 3247 |
|